![]() |
|
ORTHOCON is seeking medical sales representatives to sell its portfolio of next generation resorbable therapeutic devices to cardiac, spine, CMF, neuro, ortho, and trauma surgical specialties. The medical sales representative would join ORTHOCON as a sales consultant (1099) and will be free to sell one or all of ORTHOCON's products and non-competitive products manufactured by other organizations. ORTHOCON is a high-growth venture capital-financed company founded by Richard L. Kronenthal, Ph.D., former head of R&D at ETHICON where he developed several market-leading products during his 32-year tenure. ORTHOCON develops, manufactures, markets, and sells a portfolio of next generation resorbable therapeutic device products. In 2011, ORTHOCON announced the commercial introduction of its first 510(k) cleared product, HEMASORB Resorbable Hemostatic Bone Putty, and 510(k) clearance of HEMASORB Apply, a proprietary applicator designed to deliver HEMASORB and other ORTHOCON products presently under development. Over the next few years, ORTHOCON expects to introduce new products to the market for both bone and soft tissue applications. For more information please visit our website at www.orthocon.com or contact us by email at sell-hemasorb@orthocon.com. Read our Privacy Statement |
